Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure.
about
Interventions for paracetamol (acetaminophen) overdoseSTAT3, a Key Parameter of Cytokine-Driven Tissue Protection during Sterile Inflammation - the Case of Experimental Acetaminophen (Paracetamol)-Induced Liver DamageHospitalizations for acetaminophen overdose: a Canadian population-based study from 1995 to 2004Differential Cytotoxicity of Acetaminophen in Mouse Macrophage J774.2 and Human Hepatoma HepG2 Cells: Protection by Diallyl SulfideUbiquitin-dependent degradation of p53 protein despite phosphorylation at its N terminus by acetaminophenTAMH: A Useful In Vitro Model for Assessing Hepatotoxic MechanismsValidation of ICD-9-CM/ICD-10 coding algorithms for the identification of patients with acetaminophen overdose and hepatotoxicity using administrative data.Human bone marrow mesenchymal stem cell-derived hepatocytes improve the mouse liver after acute acetaminophen intoxication by preventing progress of injury.The role of damage associated molecular pattern molecules in acetaminophen-induced liver injury in mice.Drug-Induced Liver Injury: Cascade of Events Leading to Cell Death, Apoptosis or NecrosisThe hepatic stem cell niche: identification by label-retaining cell assay.Multiplex cDNA quantification method that facilitates the standardization of gene expression data.Differential regulation of mitogen-activated protein kinase pathways by acetaminophen and its nonhepatotoxic regioisomer 3'-hydroxyacetanilide in TAMH cells.Lactoferrin protects against acetaminophen-induced liver injury in mice.Ringer's lactate improves liver recovery in a murine model of acetaminophen toxicity.Influence of small doses of various drug vehicles on acetaminophen-induced liver injury.High mobility group B1 impairs hepatocyte regeneration in acetaminophen hepatotoxicityPregnane X receptor and drug-induced liver injury.Antidote use in the critically ill poisoned patient.Acetaminophen-NAPQI hepatotoxicity: a cell line model system genome-wide association study.HMGB1 in health and disease.Hepatoprotective activity of Tribulus terrestris extract against acetaminophen-induced toxicity in a freshwater fish (Oreochromis mossambicus).Acetaminophen-induced hepatic neutrophil accumulation and inflammatory liver injury in CD18-deficient miceProteomic analysis of acetaminophen-induced changes in mitochondrial protein expression using spectral countingOxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolaseHepatoprotective role of liver fatty acid binding protein in acetaminophen induced toxicity.HMGB1 neutralization is associated with bacterial translocation during acetaminophen hepatotoxicity.Dendritic cell depletion exacerbates acetaminophen hepatotoxicity.Role of TRAIL and the pro-apoptotic Bcl-2 homolog Bim in acetaminophen-induced liver damage.Saikosaponin d protects against acetaminophen-induced hepatotoxicity by inhibiting NF-κB and STAT3 signalingEncephalopathy in acute liver failure resulting from acetaminophen intoxication: new observations with potential therapyAcute liver failure: a life-threatening disease.Age and paracetamol self-poisoning.p53 Contributes to Differentiating Gene Expression Following Exposure to Acetaminophen and Its Less Hepatotoxic Regioisomer Both In Vitro and In Vivo.Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice?The oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta)Chemoprotective effects of a recombinant protein from Pyropia yezoensis and synthetic peptide against acetaminophen-induced Chang liver cell death.Chlorogenic acid prevents acetaminophen-induced liver injury: the involvement of CYP450 metabolic enzymes and some antioxidant signalsComplement activation in acetaminophen-induced liver injury in mice.Hepatoprotective action of various partitions of methanol extract of Bauhinia purpurea leaves against paracetamol-induced liver toxicity: involvement of the antioxidant mechanisms
P2860
Q24246166-AD3F55D6-8306-4CA8-9F52-B1DAA969CE76Q26747404-C74AE6D1-C536-4E05-9635-D1093A540651Q28218108-1B953FFB-0C38-4F54-88D9-D74576D1A963Q28551818-4C062288-EB10-42FC-8A0E-5BE4041277DFQ28579485-AE49114E-6ECF-49B9-BA2D-336D723A72A4Q28818435-7AAE856E-8915-4CA0-9D38-D5BCBFD64E68Q31131808-FFE82633-F743-4056-AF4B-05F1F64A826FQ33580844-DCE98144-75C6-44B8-A0F6-F9B8FAFC7A70Q33653566-0F060DF8-8BEA-456E-B47C-3247D4D68ACCQ33755165-95E3AC25-DB43-4B66-8F51-34E29F3DA3DFQ33760064-957388FA-FA88-4FC1-BFA5-2471F745C379Q33849607-A95C02B1-B5BD-4F81-A15D-83822067520BQ33917959-36DA52AD-DCBB-4796-9AE5-9ECCFBDA2C73Q34013719-8F7326B4-F6DD-49C9-A9E5-BA17E03CCB78Q34074958-8B04085C-A676-4B98-A3DB-B95586266E13Q34144857-464B5CB6-E361-469E-B928-DE76DB34306DQ34262481-DD4B73EE-AC89-47B6-B22D-945C7BB496F9Q34345049-659F53DA-41A0-4576-AD82-6C7121B09D18Q34562529-2EE13942-3537-455B-BCD5-FEB7E94B4206Q34601408-378F3841-54F1-4A55-A123-1E36BFBA0F29Q34622835-762A2136-16B9-43E2-8087-5F55490BEC8EQ34632884-EEC0C256-9E84-42D9-8C2E-81C354188D13Q34781465-98D06519-02AA-45E7-B057-A5F454198225Q34819836-5EE79D0D-4539-46DF-AD32-E1FB4D0BDA21Q35048149-B9ECE488-D422-4C84-A96D-E04936219E71Q35114156-FF64CB92-7498-4E5A-885B-7B05CEF801ADQ35141090-254CCB69-0F6E-40AF-9BC5-98BB0DE50334Q35195090-82FA4A4E-2CB7-4F72-848D-99C518169C0BQ35202294-71B12418-5360-493A-9511-890A0A0781F7Q35224589-C39867A2-A772-4AF5-8C61-790776D35B9AQ35387099-A45B120D-D7D6-4FBB-AFC1-A54D3576F6D8Q35565411-3A0341F9-30B6-408D-BCD5-78D364E7CF4CQ35597357-67F3355F-B539-446A-9D7F-7BAB1E66595AQ35679117-B22D65C1-EE30-4782-AABA-2E9E7AFFA453Q35792449-90CB1B73-15F8-4EA2-ACE0-B876AC22B77BQ35842779-A206BD56-E67C-4F79-A7AD-ADEABD7209F5Q35849904-DF971716-72C9-47CD-927A-37AF4A8B682FQ35864836-56315F3C-2EFC-46E7-87AD-760177BFE0ACQ35913165-A7A04BA2-3549-439F-B497-FD8903841B54Q36048880-3740D229-A26A-44E7-BBC7-066B6C3F7173
P2860
Acetaminophen and the U.S. Acute Liver Failure Study Group: lowering the risks of hepatic failure.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Acetaminophen and the U.S. Acu ...... the risks of hepatic failure.
@ast
Acetaminophen and the U.S. Acu ...... the risks of hepatic failure.
@en
Acetaminophen and the U.S. Acu ...... the risks of hepatic failure.
@nl
type
label
Acetaminophen and the U.S. Acu ...... the risks of hepatic failure.
@ast
Acetaminophen and the U.S. Acu ...... the risks of hepatic failure.
@en
Acetaminophen and the U.S. Acu ...... the risks of hepatic failure.
@nl
prefLabel
Acetaminophen and the U.S. Acu ...... the risks of hepatic failure.
@ast
Acetaminophen and the U.S. Acu ...... the risks of hepatic failure.
@en
Acetaminophen and the U.S. Acu ...... the risks of hepatic failure.
@nl
P356
P1433
P1476
Acetaminophen and the U.S. Acu ...... the risks of hepatic failure.
@en
P2093
William M Lee
P2860
P356
10.1002/HEP.20293
P407
P577
2004-07-01T00:00:00Z